Annual Total Long Term Liabilities
$114.83 M
+$28.86 M+33.57%
December 31, 2023
Summary
- As of February 26, 2025, SYRS annual total long term liabilities is $114.83 million, with the most recent change of +$28.86 million (+33.57%) on December 31, 2023.
- During the last 3 years, SYRS annual total long term liabilities has risen by +$20.76 million (+22.07%).
- SYRS annual total long term liabilities is now at all-time high.
Performance
SYRS Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$67.73 M
-$20.83 M-23.52%
September 30, 2024
Summary
- As of February 26, 2025, SYRS quarterly total long term liabilities is $67.73 million, with the most recent change of -$20.83 million (-23.52%) on September 30, 2024.
- Over the past year, SYRS quarterly long term liabilities has stayed the same.
- SYRS quarterly long term liabilities is now -42.18% below its all-time high of $117.13 million, reached on September 30, 2022.
Performance
SYRS Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
SYRS Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +33.6% | 0.0% |
| 3 y3 years | +22.1% | -9.7% |
| 5 y5 years | +1227.4% | -9.7% |
SYRS Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +73.4% | -42.2% | +20.3% |
| 5 y | 5-year | at high | +142.9% | -42.2% | +43.3% |
| alltime | all time | at high | >+9999.0% | -42.2% | +8918.1% |
Syros Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $67.73 M(-23.5%) |
| Jun 2024 | - | $88.55 M(+7.5%) |
| Mar 2024 | - | $82.37 M(-28.3%) |
| Dec 2023 | $114.83 M(+33.6%) | $114.83 M(+38.2%) |
| Sep 2023 | - | $83.10 M(+4.7%) |
| Jun 2023 | - | $79.37 M(+5.8%) |
| Mar 2023 | - | $75.02 M(-12.7%) |
| Dec 2022 | $85.97 M(+29.8%) | $85.97 M(-26.6%) |
| Sep 2022 | - | $117.13 M(+108.1%) |
| Jun 2022 | - | $56.29 M(-8.8%) |
| Mar 2022 | - | $61.75 M(-6.7%) |
| Dec 2021 | $66.21 M(-29.6%) | $66.21 M(-8.2%) |
| Sep 2021 | - | $72.10 M(-5.3%) |
| Jun 2021 | - | $76.13 M(-8.7%) |
| Mar 2021 | - | $83.38 M(-11.4%) |
| Dec 2020 | $94.07 M | $94.07 M(+58.6%) |
| Sep 2020 | - | $59.33 M(-4.6%) |
| Jun 2020 | - | $62.21 M(-4.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $65.05 M(+37.6%) |
| Dec 2019 | $47.28 M(+446.5%) | $47.28 M(+77.2%) |
| Sep 2019 | - | $26.69 M(+8.6%) |
| Jun 2019 | - | $24.58 M(+160.6%) |
| Mar 2019 | - | $9.43 M(+9.0%) |
| Dec 2018 | $8.65 M(+1051.9%) | $8.65 M(+92.2%) |
| Sep 2018 | - | $4.50 M(-9.8%) |
| Jun 2018 | - | $4.99 M(+120.3%) |
| Mar 2018 | - | $2.26 M(+201.5%) |
| Dec 2017 | $751.00 K(-34.9%) | $751.00 K(-11.2%) |
| Sep 2017 | - | $846.00 K(-9.4%) |
| Jun 2017 | - | $934.00 K(-8.6%) |
| Mar 2017 | - | $1.02 M(-11.4%) |
| Dec 2016 | $1.15 M(-29.0%) | $1.15 M(-9.9%) |
| Sep 2016 | - | $1.28 M(-8.7%) |
| Jun 2016 | - | $1.40 M(-6.9%) |
| Mar 2016 | - | $1.51 M(-7.3%) |
| Dec 2015 | $1.63 M(>+9900.0%) | $1.63 M |
| Dec 2014 | $1000.00 | - |
FAQ
- What is Syros Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Syros Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Syros Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of SYRS is $114.83 M
What is the all time high annual total long term liabilities for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high annual total long term liabilities is $114.83 M
What is Syros Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, SYRS annual total long term liabilities has changed by +$28.86 M (+33.57%)
What is Syros Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of SYRS is $67.73 M
What is the all time high quarterly long term liabilities for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high quarterly total long term liabilities is $117.13 M
What is Syros Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, SYRS quarterly total long term liabilities has changed by $0.00 (0.00%)